← All organizations

Pulmocide Ltd

For profitWebsite ↗

Also known as: Pulmocide Ltd

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jun 14, 2022

Timeline

2000s

Jan 1, 2007
Pulmocide Ltd— Founded

Drugs by trial phase (3 distinct, 9 trials)

Phase 3 (1 own, 0 via acquisition)

pc945

Phase 2 (1 own, 0 via acquisition)

tarenflurbil

Phase 1 (1 own, 0 via acquisition)

pc786

Indications

Studied for

Recent trials (10)

NCT05238116Lead sponsorPhase 3Jun 14, 2022
NCT05037851Lead sponsorPhase 2Nov 19, 2021
NCT03905447Lead sponsorPhase 2Jun 30, 2019
NCT03870841Lead sponsorPhase 2Apr 3, 2019
NCT03745196Lead sponsorPhase 2Nov 15, 2018
NCT03715023Lead sponsorPhase 2Nov 5, 2018
NCT03715023Study directorPhase 2Nov 5, 2018
NCT03382431Lead sponsorPhase 1/Phase 2Nov 14, 2017
NCT02715570Lead sponsorPhase 1Aug 1, 2017
NCT03236233Lead sponsorPhase 1Jun 21, 2017

Details

Founded: London, GB Jan 1, 2007
Last known activity: Jun 14, 2022